David Rosow, MD
Otolaryngology · Miami, FLNPI 1467619973
Payments from drug & device makers
Across 37 payments — averaging $118.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- KARL Storz Endoscopy-america$168
- Olympus America Inc.$155
- AstraZeneca$85
- C2dx, Inc$55
- Bayer$43
- plus $368 from 15 others
What the payments were for
- Travel & lodging$1,00323%
- Food & beverage$89120%
- Education$2,50057%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $3,520 |
| KARL Storz Endoscopy-america | 4 | $168 |
| Olympus America Inc. | 1 | $155 |
| AstraZeneca | 4 | $85 |
| C2dx, Inc | 1 | $55 |
| Bayer | 2 | $43 |
| Sobi, Inc | 1 | $36 |
| Taiho Oncology, Inc. | 2 | $35 |
| Merck | 2 | $30 |
| Novartis | 1 | $29 |
| Immunocore Limited | 1 | $29 |
| Incyte Corporation | 1 | $27 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| Bristol Myers Squibb | 2 | $25 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Exelixis Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Sanofi | 1 | $14 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$2,500
- Da Vinci Surgical System$984
- Olympus$155
- RHINO-LARYNGO FIBERSCOPE$155
How this compares
$4,394 in reported general payments places this provider in the 75th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 33 | $627 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $367 |
| Amitriptyline Hcl | 36 | $215 |
| Prednisone | 21 | $125 |
| Methylprednisolone | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Miami
- Adrien EshraghiMiami$2.1M
- Maria SuurnaMiami$456K
- Corinna LevineMiami$112K
- Agustin ArrietaMiami$95K
- Abraham JaguanMiami$74K
- Francisco PernasMiami$70K
- Michael HofferMiami$32K
- Andres OrjuelaMiami$30K
- Roy CasianoMiami$26K
- Jason LeibowitzMiami$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.